Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Alabama Medical Policy Updates – July 2018
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
July 2018 BCBS Alabama Medical Policy Updates:
- Addyi Prior Authorization and Quantity Limit Criteria Program Summary
- Afrezza Prior Authorization with Quantity Limit Criteria Program Summary
- Ampyra™ (dalfampridine) Prior Authorization and Quantity Limit Program Summary
- Aqueous Shunts and Stents for Glaucoma
- Automated Ambulatory Blood Pressure
- Automated Point-of-Care Nerve Conduction Tests
- Bone Mineral Density Testing
- Bonjesta, Diclegis Prior Authorization with Quantity Limit Criteria Program
- Buprenorphine and Buprenorphine-Naloxone for Opioid Dependence Prior Authorization and Quantity Limit Criteria Program Summary
- Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
- Contraceptive Prior Authorization Criteria
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prior Authorization with Quantity Limit Program Summary
- Cytochrome P450 Genotyping Genotype-Guided Treatment Strategy
- Endovascular Stent Grafts for Abdominal Aortic Aneurysms
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- Genetic Testing for Genotype-Guided Warfarin Dosing
- Growth Hormone Prior Authorization Criteria Program Summary
- Idiopathic Pulmonary Fibrosis Prior Authorization with Quantity Limit Criteria Program Summary
- Inhaled Antibiotics Duplicate Therapy Program Summary
- Insulin Prior Authorization Criteria Program Summary
- Low-Level Laser and High-Power Laser Therapies
- Lyrica (pregabalin CR) Prior Authorization with Quantity Limit Program Summary
- Measurement of Serum Antibodies to Infliximab, Adalimumab, and Vedolizumab
- Metformin ER Step Therapy Criteria Program Summary
- Methotrexate Injectable Step Therapy Criteria Program Summary
- Multibiomarker Disease Activity Blood Test Vectra DA Blood Test for Rheumatoid Arthritis
- Multiple Sclerosis Agents Prior Authorization with Quantity Limit Program Summary
- Neuromuscular and Electrodiagnostic Testing (EDX): Nerve Conduction Studies (NCS) and Electromyography (EMG) Studies
- Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)
- Patient-Specific Instrumentation for Joint Arthroplasty
- Quantitative Sensory Testing (QST)
- Self-Administered Oncology Agents Prior Authorization with Quantity Limit Criteria Program Summary
- Statin Step Therapy Criteria Program Summary
- Substrate Reduction Therapy Prior Authorization with Quantity Limit Criteria Program Summary
- Three-Dimensional Printed Orthopedic Implants
- Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Criteria Program Summary
- Transcatheter Pulmonary Valve Implantation
- Transmucosal Immediate Release Fentanyl Prior Authorization (Through Generic) and Quantity Limit Criteria Program Summary
- Xanthine Oxidase Inhibitor Step Therapy with Quantity Limit Criteria Program Summary
- Xyrem (sodium oxybate) Prior Authorization with Quantity Limit Criteria Program Summary
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
